1. Home
  2. TNYA vs AURE Comparison

TNYA vs AURE Comparison

Compare TNYA & AURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.73

Market Cap

159.6M

Sector

Health Care

ML Signal

HOLD

AURE

Prestige Wealth Inc. Class A Ordinary Shares

N/A

Current Price

$0.24

Market Cap

86.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TNYA
AURE
Founded
2016
2018
Country
United States
Hong Kong
Employees
N/A
4
Industry
Medicinal Chemicals and Botanical Products
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
159.6M
86.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TNYA
AURE
Price
$0.73
$0.24
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$5.25
N/A
AVG Volume (30 Days)
3.8M
162.3K
Earning Date
03-09-2026
01-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,785,569.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
434.30
52 Week Low
$0.36
$0.23
52 Week High
$2.35
$2.70

Technical Indicators

Market Signals
Indicator
TNYA
AURE
Relative Strength Index (RSI) 36.85 N/A
Support Level $0.70 N/A
Resistance Level $0.78 N/A
Average True Range (ATR) 0.05 0.00
MACD 0.02 0.00
Stochastic Oscillator 32.66 0.00

Price Performance

Historical Comparison
TNYA
AURE

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.

About AURE Prestige Wealth Inc. Class A Ordinary Shares

Aurelion Inc is engaged in providing private wealth management and asset management services to high-net-worth and ultra-high-net-worth individuals by identifying and purchasing well-matched wealth management products offered by third-party providers. Its subsidiary operates a wealth management business that works with licensed product brokers in Hong Kong, currently consisting solely of insurance brokers distributing insurance products, and assists in customizing wealth management investment portfolios for clients. The Company generates revenue for its subsidiaries' wealth management business from product brokers in the form of referral fees, which are calculated based on the value of wealth management products purchased by clients from such brokers.

Share on Social Networks: